Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Convalescent Plasma Therapy Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, there has been a swift expansion in the size of the convalescent plasma therapy market. The market’s growth is expected to rise from $0.05 billion in 2024 to $0.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.4%. The unprecedented growth experienced in the historical period can be linked to occurrences such as pandemics and outbreaks of infectious diseases, advancements in immunotherapy research, the implementation of emergency use authorization (eua), the availability of patients, and a heightened awareness amongst clinicians and the general public.

What Is the Forecast for the Convalescent Plasma Therapy Market Size Through 2029?

Anticipations are high for a swift expansion of the convalescent plasma therapy market in the coming years. By 2029, it is projected to reach a market size of $0.09 billion, exhibiting a Compound Annual Growth Rate (CAGR) of 13.7%. The acceleration during the forecast period is likely due to the evolution of pathogens, progress in immunotherapies, administrative structures, global readiness, and public health programs. Key trends during this forecast period are expected to be the standardization of collection and processing, focus on specific plasma components, personalized care approaches, advancements in telemedicine and remote monitoring, as well as research on long-term impacts.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

What are the Key Market Players in Convalescent Plasma Therapy Market and How They’re Evolving?

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

What Are the Primary Growth Drivers in the Convalescent Plasma Therapy Market?

The growth of the CPT market during the forecast period can be fueled by the high efficacy and safety demonstrated during trials on COVID-19 patients. Traditionally, convalescent plasma transfusion has been used in addressing other outbreaks of infectious diseases such as SARS‐1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In a study led by the Houston Methodist hospital in June 2022, the safety and effectiveness of COVID-19 convalescent plasma therapy were evaluated, demonstrating that the therapy is safe, with no adverse events recorded, and showed a productivity of 76% in recovery rate. Another study published in the Journal of Medical Virology in May 2020 suggested that the use of convalescent plasma therapy can mitigate mortality rates among severely sick patients, present favorable effects on clinical symptoms, and lead to an elevation in neutralizing antibody titers and disappearance of SARS‐CoV‐2 RNA. These results demonstrating the safety and efficacy of convalescent plasma therapy in treating COVID-19 patients is likely to stimulate the progress of the global convalescent plasma therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp

What Are the Leading Segments in the Global Convalescent Plasma Therapy Industry?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products

What Are the Key Market Trends in the Convalescent Plasma Therapy Industry?

The progress in antibody-based immunotherapy as a potential treatment method for COVID-19 indicates potential growth for the convalescent plasma therapy market. This therapy leverages antibodies generated against the coronavirus by the donor to strengthen the recipient’s immune system. Corporations are commencing trials, affiliations, and investments in antibody-centered COVID-19 therapy. In August 2023, U.S. biotech company Regeneron Pharmaceuticals Inc. partnered with the Biomedical Advanced Research and Development Authority (BARDA) to support the clinical advancement, manufacture, and licensing regulations for the forthcoming COVID-19 monoclonal antibody therapy aimed at blocking SARS-CoV-2 infection. This partnership is a segment of Project NextGen, an initiative by the U.S. Department of Health and Human Services (HHS) to establish a string of updated COVID-19 vaccines and treatments. In line with the project’s design, Regeneron will autonomously build and introduce an antibody candidate, which BARDA and Regeneron will evaluate and pick for further study, production, and licensing processes. The emphasis on antibody-based COVID-19 therapy, which is a key component of convalescent plasma therapy, is projected to stimulate market expansion.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

What Is the Regional Outlook for the Convalescent Plasma Therapy Market?

North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3233

This Report Delivers Insight On:

1. How big is the convalescent plasma therapy market, and how is it changing globally?

2. Who are the major companies in the convalescent plasma therapy market, and how are they performing?

3. What are the key opportunities and risks in the convalescent plasma therapy market right now?

4. Which products or customer segments are growing the most in the convalescent plasma therapy market?

5. What factors are helping or slowing down the growth of the convalescent plasma therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model